Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	27314-97-2
Formula :	C₇H₆N₄O₂
M.W :	178.15
SMILES Code :	NC1=[N+]([O-])C2=CC=CC=C2[N+]([O-])=N1
Synonyms :	Tirazone; Win59075; 3-Amino-1,2,4-benzotriazine 1,4-Dioxide
MDL No. :	MFCD00132954
InChI Key :	ORYDPOVDJJZGHQ-UHFFFAOYSA-N
Pubchem ID :	135413511

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H315-H319-H335
Precautionary Statements:	P261-P305+P351+P338

UV41 Chinese hamster ovary cells	6 µM	1 hour	Evaluate the cell-killing effect of TPZ combined with cisplatin, showing no enhancement of cisplatin toxicity by TPZ in ERCC4-deficient UV41 cells	Br J Cancer. 1999 Jun;80(8):1245-51
AA8 Chinese hamster ovary cells	18 µM	1 hour	Evaluate the cell-killing effect of TPZ combined with cisplatin, showing that TPZ pretreatment under hypoxia significantly enhances cisplatin cytotoxicity	Br J Cancer. 1999 Jun;80(8):1245-51
LXFL 529 human non-small-cell lung cancer cells	20 µM	1 hour	Evaluate the cell-killing effect of TPZ combined with cisplatin, showing that TPZ pretreatment under hypoxia significantly enhances cisplatin cytotoxicity	Br J Cancer. 1999 Jun;80(8):1245-51
NIH 3T3 mouse fibroblast cells	20 µM	1 hour	Evaluate the cell-killing effect of TPZ combined with cisplatin, showing that TPZ pretreatment under hypoxia significantly enhances cisplatin cytotoxicity	Br J Cancer. 1999 Jun;80(8):1245-51
CT26 mouse colon carcinoma cells	0 to 200 µg/mL	24 hours	To evaluate the toxicity of TCuH NPs on CT26 cells, results showed that the cell viability was approximately 31.2% in the TCuH + 1064 nm laser irradiation group.	J Nanobiotechnology. 2024 Apr 24;22(1):205
1205 Lu P cells	20 mM	24 hours	Compare the response of normal keratinocytes and melanoma cells expressing different connexins to NTP + TPZ treatment	Cells. 2023 Aug 21;12(16):2113
B16-F10 cells	27.95 mM (TPZ alone) and 17.44 mM (NTP + TPZ)	24 hours	Determine the IC50 of TPZ under hypoxic conditions and demonstrate the synergistic effect of NTP and TPZ combination therapy	Cells. 2023 Aug 21;12(16):2113
143B cells	40 µg/mL	3 hours	Evaluate cell viability and apoptosis, results showed that TPZ/PFA@UiO-66@PDA significantly enhanced hypoxia, induced cell apoptosis in vitro through the oxygen-dependent HIF-1α pathway.	J Nanobiotechnology. 2021 Sep 30;19(1):298
A549 wild type cells	10, 25, 50, 100 µM	6 monthourss	To evaluate the biochemical consequences of chronic aerobic tirapazamine exposure, it was found that cells developed significant aerobic resistance to TPZ, with elevated MnSOD levels and reduced DT-diaphorase and P450R activity.	Br J Cancer. 2000 Feb;82(3):651-6

BALB/c mice	4T1 breast cancer model	Tail vein injection	1 mg/kg (TPZ), 3 mg/kg (BMS)	Every 3 days, total of 4 times	Evaluate the anti-tumor efficacy of PEI-FA@IR@TPZ/BMS LPs in the 4T1 breast cancer model. Results showed that PEI-FA@IR@TPZ/BMS LPs significantly inhibited tumor growth and reduced lung metastatic nodules. Additionally, the nanoplatform enhanced immune responses, as evidenced by increased CD4+ and CD8+ T cells and decreased Tregs.	J Nanobiotechnology. 2024 Sep 12;22(1):558.
BALB/c nude mice	Subcutaneous 143B tumor model	Tail vein injection	10 mg/kg	Injected on days 0, 4, and 8, lasting for 16 days	Evaluate the anti-tumor effect of TPZ/PFA@UiO-66@PDA in vivo, results showed that nanoparticles accumulated in the tumor region and effectively inhibited tumor growth.	J Nanobiotechnology. 2021 Sep 30;19(1):298
Nude mice	HRT18 and Nal1+ xenografted tumors	Intraperitoneal injection	144 mg/kg	Four consecutive days	To evaluate the toxicity and activity of tirapazamine alone or combined with chemotherapeutic agents. Results showed that tirapazamine combined with bleomycin or VP16 significantly increased tumor regrowth delay and cytotoxicity.	Br J Cancer. 1996 Jun;73(12):1480-5
BALB/c nude mice	4T1 breast cancer model	Intravenous injection	2 mg/kg	Administered on days 1, 4, 7, 10, 13, and 16, lasting for 16 days	Evaluate the antitumor effect of GPPCT nanoplatforms in vivo. Results showed that GPPCT specifically accumulates at tumor sites, effectively inhibits tumor growth and metastasis through the combination of CDT and chemotherapy, with no systemic toxicity	J Nanobiotechnology. 2022 Jan 21;20(1):43
C57BL/6 mice	B16-F10 melanoma model	Intratumoral injection	20 μM TPZ	5 treatments in total, every 2-3 days	Evaluate the inhibitory effect of NTP + TPZ combination therapy on melanoma growth, showing significant reduction in tumor volume and increased tumor cell death and necrosis	Cells. 2023 Aug 21;12(16):2113
BDF and C3H mice	T50/80 mammary carcinoma, SCCVII and RIF-1 tumour models	Intraperitoneal injection	25-50 mg/kg	Single dose, varying from 30 minutes to 24 hours	To evaluate the anti-tumour effect and toxicity to normal bone marrow of tirapazamine in combination with cyclophosphamide. Results showed that tirapazamine at 25 mg/kg combined with cyclophosphamide (100 mg/kg) produced an anti-tumour effect equivalent to a single 150 mg/kg dose of cyclophosphamide alone. However, tirapazamine significantly increased toxicity to bone marrow cells.	Br J Cancer. 2000 Apr;82(8):1469-73
HBx transgenic mice	Spontaneous HCC model in HBx transgenic mice	Tail vein injection	3 mg/kg	Single dose, followed for up to 7 days	To evaluate the efficacy of TPZ combined with hepatic artery ligation (HAL), results showed nearly complete necrosis (～99%) of HCC.	Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):11937-11942
BALB/c nude mice	Subcutaneous colon cancer model	Tail vein injection	5 mg/kg	Once every other day for five total treatments	To evaluate the antitumor efficacy of TCuH NPs in vivo, results showed that the tumor inhibition rate in the TCuH + 1064 nm laser group was 92.3%.	J Nanobiotechnology. 2024 Apr 24;22(1):205
C57BL/6 mice	RM-1 tumor model	Implantation	5 μg/g	Single implantation, lasting 10 days	To evaluate the inhibitory effect of CA4P@S-TPZ@F-CA4P@S on postoperative tumor recurrence and metastasis, showing effective inhibition of tumor recurrence and metastasis.	Adv Sci (Weinh). 2023 Aug;10(22):e2300899

{[proInfo.proName]}

CAS No.: 27314-97-2

{[proInfo.proName]}

CAS No.: 27314-97-2

Alternative Products

Product Details of Tirapazamine

Safety of Tirapazamine

Related Pathways of Tirapazamine

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed